Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma

105AD7 is a human monoclonal antibody that mimics the complement regulatory protein, CD55, overexpressed by many solid tumours including osteosarcoma. This study was designed to assess the toxicity and efficacy of this vaccine in a young age group of patients within 1–6 months of myleosuppressive ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Pritchard-Jones, K, Spendlove, I, Wilton, C, Whelan, J, Weeden, S, Lewis, I, Hale, J, Douglas, C, Pagonis, C, Campbell, B, Alvarez, P, Halbert, G, Durrant, L G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361999/
https://www.ncbi.nlm.nih.gov/pubmed/15798769
http://dx.doi.org/10.1038/sj.bjc.6602500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361999/
https://www.ncbi.nlm.nih.gov/pubmed/15798769
http://dx.doi.org/10.1038/sj.bjc.6602500

Ejemplares similares